Disease: Glioblastoma
- "Pushing the Envelope": advanced imaging-data-analysis meets NODDI to differentiate glioblastoma and brain metastasis
- A comparison study of dynamic [(18)F]Alfatide II imaging and [(11)C]MET in orthotopic rat models of glioblastoma
- A heterogeneous pharmaco-transcriptomic landscape induced by targeting a single oncogenic kinase
- A Monte Carlo simulation-based decision support system for radiation oncologists in the treatment of glioblastoma multiforme
- A New Sarcoma Shortly after Treatment for High-Grade Glioma with Adjuvant Chemoradiation: A Case Report
- A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians
- A systematic computational analysis of the endosomal recycling pathway in glioblastoma
- A tale of two tumors: differential, but detrimental, effects of glioblastoma extracellular vesicles (EVs) on normal human brain cells
- A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients
- Advances in glioblastoma multiforme: Integrating therapy and pathology perspectives
- An atlas of causal and mechanistic drivers of interpatient heterogeneity in glioma
- An exploration of causal relationships between nine neurological diseases and the risk of breast cancer: a Mendelian randomization study
- Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma
- Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner
- Automatic brain-tumor diagnosis using cascaded deep convolutional neural networks with symmetric U-Net and asymmetric residual-blocks
- Autophagy cooperates with PDGFRA to support oncogenic growth signaling
- BAG3 regulates cilia homeostasis of glioblastoma via its WW domain
- Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors
- Bone marrow mesenchymal stromal cell-derived exosomal NRF2 ameliorates cerebral ischemia-reperfusion injury by transcriptionally activating Lin28a
- CDPNet: a radiomic feature learning method with epigenetic application to estimating MGMT promoter methylation status in glioblastoma
- Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma
- Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics
- Combined ion beam irradiation platform and 3D fluorescence microscope for cellular cancer research
- Comprehensive analysis of CYBB as a prognostic marker and therapeutic target in glioma: A bioinformatics approach
- Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status
- Correction: Dastghaib et al. Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells. Cells 2020, 9, 2339
- Correction: Relevance of Thymic Stromal Lymphopoietin on the Pathogenesis of Glioblastoma: Role of the Neutrophil
- Corrigendum to "Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial" [Eur J Cancer 198 (2024) 113475]
- Design, Synthesis, and Investigation of the Pharmacokinetics and Anticancer Activities of Indenoisoquinoline Derivatives That Stabilize the G-Quadruplex in the <em>MYC</em> Promoter and Inhibit Topoisomerase I
- Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy
- DIMet: An open-source tool for Differential analysis of targeted Isotope-labeled Metabolomics data
- Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence
- Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy
- E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability
- ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification
- Emerging cytokine delivery with nanomedicine for brain cancer treatment
- Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients
- Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients
- Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
- GBM Immunotherapy: Macrophage Impacts
- Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data
- Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4
- Glioblastoma mechanobiology at multiple length scales
- GPR27 expression correlates with prognosis and tumor progression in gliomas
- hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study
- ID1(high)/activin A(high) glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature
- Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
- Identification of Prognostic Markers of Glioblastoma through Bioinformatics Analysis
- Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?
- In situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response
- Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging
- Inhibition of signaling protein ERN1 increases the sensitivity of serine synthesis gene expressions to glucose and glutamine deprivations in U87MG glioblastoma cells
- Integrating multisector molecular characterization into personalized peptide vaccine design for patients with newly diagnosed glioblastoma
- Integrative spatial analysis reveals a multi-layered organization of glioblastoma
- Investigating Causal Genetic Effects on Overall Survival of Glioblastoma Patients using Normalizing Flow and Structural Causal Model
- LOX rises as a potential survival biomarker: A commentary on "Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme" by Liu et al
- Miniature, multi-dichroic instrument for measuring the concentration of multiple fluorophores
- Mocetinostat as a novel selective histone deacetylase (HDAC) inhibitor in the promotion of apoptosis in glioblastoma cell line C6 and T98G
- Modular Hub Genes in DNA Microarray Suggest Potential Signaling Pathway Interconnectivity in Various Glioma Grades
- Molecular diversity in isocitrate dehydrogenase-wild-type glioblastoma
- Mondrian Map: Piet Mondrian's Abstraction for Differential Pathway Analysis
- Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma
- New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and In Vitro Effect on Glioblastoma
- Non-Detection of HCMV Total Genomic DNA in Human Glioma Cells Genome
- Paroxysmal Sympathetic Hyperactivity in the Acute Phase Post-Brain Tumour Surgery of Glioblastoma Multiforme
- PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview
- Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
- Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma
- Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies - do we know enough to overcome this?
- Polyphenols Modulate the miRNAs Expression that Involved in Glioblastoma
- Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms
- PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-beta-catenin pathway
- Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer database
- Prognosis and therapeutic significance of IGF-1R-related signaling pathway gene signature in glioma
- Prognostic biomarker TPM4 acts as a potential predictor of PD-1/PD-L1 inhibitor response in glioblastoma
- Prognostic Value of ATRX and p53 Status in High-Grade Glioma Patients in Morocco
- Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review)
- Radio-anatomical evaluation of clinical and radiomic profile of multi-parametric magnetic resonance imaging of de novo glioblastoma multiforme
- Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma
- Radiomics for predicting MGMT status in cerebral glioblastoma: comparison of different MRI sequences
- RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma
- Resection of supratentorial high-grade gliomas availing of neuronavigation matched intraoperative ultrasound and Fluorescein: How far is it safe to push the resection?
- Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps
- Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma
- Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis
- Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche
- Spliced FKBP51s predicts unfavorable prognosis of glioblastoma patients
- Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?
- STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma
- Structural changes in corticospinal tract profiling via multishell diffusion models and their relation to overall survival in glioblastoma
- Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy
- Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics
- The ins and outs of microglial cells in brain health and disease
- The Myc-associated zinc finger protein epigenetically controls expression of interferon-γ-stimulated genes by recruiting STAT1 to chromatin
- The RAS oncogene in brain tumors and the involvement of let-7 microRNA
- Theranostic Bottle-Brush Polymers Tailored for Universal Solid-Tumor Targeting
- Treatment advances in high-grade gliomas
- Ultrasmall iron oxide nanoparticles with MRgFUS for enhanced magnetic resonance imaging of orthotopic glioblastoma
- Urease and human glioblastoma (U87) cells growth inhibitory iridoid glycoside acetates from Nyctanthes arbor-tristis Linn
- USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization